Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Learn why stock market indices matter for benchmark reporting, performance comparison, and portfolio context in everyday investing.
28,200 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A Wall Street titan is backing Crypto.com with a substantial investment, signaling a new era of cross-market liquidit...
SPY trades near $668 amid rising oil to $100 and a higher VIX, yet retail traders on social forums stay bullish. The ...
Leveraged ETFs promise outsized gains, but their daily reset can distort long-term results. This guide breaks down ho...
After months of sideways movement, the stock market just this week flashed a hopeful sign. This article dives into wh...
The stock market is flirting with a milestone not seen in 155 years. This article explains what a stock market verge ...
As the AI era expands, investors are eyeing a broader landscape beyond Nvidia. This article explores a rising AI infr...
When building a portfolio, you face a choice between global exposure and an emerging markets tilt. This guide breaks ...
Shay Capital reduced its PureCycle stake in the latest 13F filing, prompting questions about the stock's future. This...
As the Federal Reserve prepares to announce policy, market nerves rise and major indexes stumble. This guide breaks d...
On this stock market today, feb., Blue Owl Capital grabbed attention as it tightens withdrawals in a key fund and sel...
The Nasdaq leads the charge as risk appetite returns, lifting major indices. This guide breaks down what’s driving th...